(1) Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil1967; 12(1 Pt 2):77-126.

(2) Vollman RF. The Menstrual Cycle. Philadelphia: WB Saunders, 1977.

(3) Presser HB. Temporal data relating to the human menstrual cycle. In: Ferin M, Halber F, Richart RM, et al, editors. Biorhythms and Human Reproduction. New York: John Wiley and Sons, 1974: 145-160.

(4) Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966; 45(3):320-351.

(5) Apter D, Raisanen I, Ylostalo P, Vihko R. Follicular growth in relation to serum hormonal patterns in adolescent compared with adult menstrual cycles. Fertil Steril 1987; 47(1):82-88.

(6) Fraser IS, Michie EA, Wide L, Baird DT. Pituitary gonadotropins and ovarian function in adolescent dysfunctional uterine bleeding. J Clin Endocrinol Metab 1973; 37(3):407-414.

(7) Lenton EA, Landgren BM, Sexton L, Harper R. Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol 1984; 91(7):681-684.

(8) Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996; 81(4):1401-1405.

(9) Welt CK, Pagan YL, Smith PC, Rado KB, Hall JE. Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab 2003; 88(4):1766-1771.

(10) Tsafriri A. Local nonsteroidal regulators of ovarian function. In: Knobil E, Neill JD, et al, editors. The physiology of reproduction. New York: Raven, 1994: 817-860.

(11) Sawetawan C, Carr BR, McGee E, Bird IM, Hong TL, Rainey WE. Inhibin and activin differentially regulate androgen production and 17 alpha-hydroxylase expression in human ovarian thecal-like tumor cells. J Endocrinol 1996; 148(2):213-221.

(12) Welt CK, Martin KA, Taylor AE, Lambert-Messerlian GM, Crowley WF, Jr., Smith JA et al. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab 1997; 82(8):2645-2652.

(13) Amsterdam A, Rotmensch S. Structure-function relationships during granulosa cell differentiation. Endocr Rev1987; 8(3):309-337.

(14) Nimrod A, Erickson GF, Ryan KJ. A specific FSH receptor in rat granulosa cells: properties of binding in vitro. Endocrinology1976; 98(1):56-64.

(15) Fink G. Gonadotropin secretion and its control. In: Knobil E, Neill JD, et al, editors. The physiology of reproduction. New York: Raven, 1988: 1349-1377.

(16) Zeleznik AJ, Midgley AR, Jr., Reichert LE, Jr. Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology1974; 95(3):818-825.

(17) Erickson GF, Wang C, Hsueh AJ. FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature1979; 279(5711):336-338.

(18) McNatty KP, Makris A, Reinhold VN, De Grazia C, Osathanondh R, Ryan KJ. Metabolism of androstenedione by human ovarian tissues in vitro with particular reference to reductase and aromatase activity. Steroids1979; 34(4):429-443.

(19) Young JR, Jaffe RB. Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. II. Effects of varying concentrations of estradiol. J Clin Endocrinol Metab 1976; 42(3):432-442.

(20) Reame N, Sauder SE, Kelch RP, Marshall JC. Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion. J Clin Endocrinol Metab 1984; 59(2):328-337.

(21) Zhou J, Bondy C. Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod 1993; 48(3):467-482.

(22) Maruo T, Ladines-Llave CA, Samoto T, Matsuo H, Manalo AS, Ito H et al. Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression. Endocrinology1993; 132(2):924-931.

(23) Hillier SG, van den Boogaard AM, Reichert LE, Jr., van Hall EV. Intraovarian sex steroid hormone interactions and the regulation of follicular maturation: aromatization of androgens by human granulosa cells in vitro. J Clin Endocrinol Metab 1980; 50(4):640-647.

(24) Pauerstein CJ, Eddy CA, Croxatto HD, Hess R, Siler-Khodr TM, Croxatto HB. Temporal relationships of estrogen, progesterone, and luteinizing hormone levels to ovulation in women and infrahuman primates. Am J Obstet Gynecol 1978; 130(8):876-886.

(25) Cahill DJ, Wardle PG, Harlow CR, Hull MG. Onset of the preovulatory luteinizing hormone surge: diurnal timing and critical follicular prerequisites. Fertil Steril 1998; 70(1):56-59.

(26) Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab 1983; 57(4):792-796.

(27) Channing CP, Schaerf FW, Anderson LD, et al. Ovarian follicular and luteal physiology. In: Greep RO, editor. International Review of Physiology. Baltimore: University Park Press, 1980: 117.

(28) Espey LL, Lipner H. Ovulation. In: Knobil E, Neill JD, editors. The Physiology of Reproduction. New York: Raven, 1994: 725.

(29) Espey LL. Ovarian proteolytic enzymes and ovulation. Biol Reprod1974; 10(2):216-235.

(30) Lousse JC, Donnez J. Laparoscopic observation of spontaneous human ovulation. Fertil Steril 2008; 90(3):833-834.

(31) Fukuda M, Fukuda K, Andersen CY, Byskov AG. Right-sided ovulation favours pregnancy more than left-sided ovulation. Hum Reprod2000; 15(9):1921-1926.

(32) Lumsden MA, Kelly RW, Templeton AA, Van Look PF, Swanston IA, Baird DT. Changes in the concentration of prostaglandins in preovulatory human follicles after administration of hCG. J Reprod Fertil1986; 77(1):119-124.

(33) Espey LL, Tanaka N, Adams RF, Okamura H. Ovarian hydroxyeicosatetraenoic acids compared with prostanoids and steroids during ovulation in rats. Am J Physiol 1991; 260(2 Pt 1):E163-E169.

(34) Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976; 42(4):629-636.

(35) O'Grady JP, Caldwell BV, Auletta FJ, Speroff L. The effects of an inhibitor of prostaglandin synthesis (indomethacin) on ovulation, pregnancy, and pseudopregnancy in the rabbit. Prostaglandins1972; 1(2):97-106.

(36) Killick S, Elstein M. Pharmacologic production of luteinized unruptured follicles by prostaglandin synthetase inhibitors. Fertil Steril1987; 47(5):773-777.

(37) Pall M, Friden BE, Brannstrom M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Hum Reprod 2001; 16(7):1323-1328.

(38) Doody KJ, Carr BR. Diagnosis and treatment of luteal dysfunction. In: Hillier SG, editor. Ovarian Endocrinology. London: Blackwell Scientific, 1991: 260.

(39) Katt JA, Duncan JA, Herbon L, Barkan A, Marshall JC. The frequency of gonadotropin-releasing hormone stimulation determines the number of pituitary gonadotropin-releasing hormone receptors. Endocrinology1985; 116(5):2113-2115.

(40) Koos RD. Potential relevance of angiogenic factors to ovarian physiology. Semin Reprod Endocrinol 1989; 7:29.

(41) Niswender GD, Nett TM. The corpus luteum and its control in infraprimate species. In: Knobil E, Neill JD, editors. The Physiology of Reproduction. New York: Raven, 1994: 781.

(42) Retamales I, Carrasco I, Troncoso JL, Las HJ, Devoto L, Vega M. Morpho-functional study of human luteal cell subpopulations. Hum Reprod1994; 9(4):591-596.

(43) Khan-Dawood FS, Goldsmith LT, Weiss G, Dawood MY. Human corpus luteum secretion of relaxin, oxytocin, and progesterone. J Clin Endocrinol Metab1989; 68(3):627-631.

(44) Carr BR, Mcgee EA, Sawetawan C, Clyne CD, Rainey WE. The effect of transforming growth factor-beta on steroidogenesis and expression of key steroidogenic enzymes with a human ovarian thecal-like tumor cell model. Am J Obstet Gynecol 1996; 174(4):1109-1116.

(45) Vande Wiele RL, Bogumil J, Dyrenfurth I, Ferin M, Jewelewicz R, Warren M et al. Mechanisms regulating the menstrual cycle in women. Recent Prog Horm Res 1970; 26:63-103.

(46) SEGALOFF A, STERNBERG WH, GASKILL CJ. Effects of luteotropic dose of chorionic gonadotropin in women. J Clin Endocrinol Metab 1951; 11(9):936-944.

(47) Filicori M, Butler JP, Crowley WF, Jr. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 1984; 73(6):1638-1647.

(48) McNeely MJ, Soules MR. The diagnosis of luteal phase deficiency: a critical review. Fertil Steril 1988; 50(1):1-15.

(49) Stouffer RL, Hodgen GD. Induction of luteal phase defects in rhesus monkeys by follicular fluid administration at the onset of the menstrual cycle. J Clin Endocrinol Metab 1980; 51(3):669-671.

(50) Sheehan KL, Casper RF, Yen SS. Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control. Science1982; 215(4529):170-172.

(51) Keyes PL, Wiltbank MC. Endocrine regulation of the corpus luteum. Annu Rev Physiol 1988; 50:465-482.

(52) Cooke ID. The corpus luteum. Hum Reprod 1988; 3(2):153-156.

(53) Auletta FJ, Flint AP. Mechanisms controlling corpus luteum function in sheep, cows, nonhuman primates, and women especially in relation to the time of luteolysis. Endocr Rev 1988; 9(1):88-105.

(54) Hodgen GD. Surrogate embryo transfer combined with estrogen-progesterone therapy in monkeys. Implantation, gestation, and delivery without ovaries. JAMA1983; 250(16):2167-2171.

(55) Gore BZ, Caldwell BV, Speroff L. Estrogen-induced human luteolysis. J Clin Endocrinol Metab 1973; 36(3):615-617.

(56) Iwai T, Nanbu Y, Iwai M, Taii S, Fujii S, Mori T. Immunohistochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle. Virchows Arch A Pathol Anat Histopathol 1990; 417(5):369-375.

(57) Wentz AC, Jones GS. Transient luteolytic effect of prostaglandin F2alpha in the human. Obstet Gynecol 1973; 42(2):172-181.

(58) Schoonmaker JN, Bergman KS, Steiner RA, Karsch FJ. Estradiol-induced luteal regression in the rhesus monkey: evidence for an extraovarian site of action. Endocrinology1982; 110(5):1708-1715.

(59) Shikone T, Yamoto M, Kokawa K, Yamashita K, Nishimori K, Nakano R. Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. J Clin Endocrinol Metab 1996; 81(6):2376-2380.

(60) Khan-Dawood FS, Huang JC, Dawood MY. Baboon corpus luteum oxytocin: an intragonadal peptide modulator of luteal function. Am J Obstet Gynecol1988; 158(4):882-891.

(61) Young KA, Hennebold JD, Stouffer RL. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. Mol Hum Reprod 2002; 8(9):833-840.

(62) Judd HL, Yen SS. Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab 1973; 36(3):475-481.

(63) Genazzani AR, Lemarchand-Beraud T, Aubert ML, Felber JP. Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle. J Clin Endocrinol Metab 1975; 41(3):431-437.

(64) Carr BR, Parker CR, Jr., Madden JD, MacDonald PC, Porter JC. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. J Clin Endocrinol Metab 1979; 49(3):346-349.

(65) Carr BR, Wilson JD. Disorders of the ovary and the female reproductive tract. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, editors. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1987: 1818.

(66) Casey ML, MacDonald PC. Extraadrenal formation of a mineralocorticosteroid: deoxycorticosterone and deoxycorticosterone sulfate biosynthesis and metabolism. Endocr Rev 1982; 3(4):396-403.

(67) Parker CR, Jr., Winkel CA, Rush AJ, Jr., Porter JC, MacDonald PC. Plasma concentrations of 11-deoxycorticosterone in women during the menstrual cycle. Obstet Gynecol 1981; 58(1):26-30.

(68) Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975; 122(2):262-263.

(69) Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS, Jr. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab1988; 67(2):334-340.

(70) Tseng L, Liu HC. Stimulation of arylsulfotransferase activity by progestins in human endometrium in vitro. J Clin Endocrinol Metab1981; 53(2):418-421.

(71) Rebar RE. Practical evaluation of hormonal status. In: Yen SSC, Jaffe RB, editors. Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. Philadelphia: WB Saunders, 1991: 830.

(72) Gaudefroy M. Cytologic criteria of estrogen effect. Acta Cytol1958;(2):347.

(73) Henzl MR, Smith RE, Boost G, Tyler ET. Lysosomal concept of menstrual bleeding in humans. J Clin Endocrinol Metab 1972; 34(5):860-875.

(74) Turksoy RN, Safaii HS. Immediate effect of prostaglandin F2alpha during the luteal phase of the menstrual cycle. Fertil Steril1975; 26(7):634-637.

(75) Edman CD. The effects of steroids on the endometrium. Semin Reprod Endocrinol1983; 1(3):179.

(76) Curry TE, Jr., Osteen KG. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 2001; 64(5):1285-1296.